genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Gilead Sciences
A-Lists
Top 10 Best Selling Drugs
A-Lists
Top 10 Best-Selling Cell and Gene Therapies
Drug Discovery
StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
Drug Discovery
Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio
Cancer
Key Characteristics Associated with Improved CAR-T Outcomes Identified
Drug Discovery
StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers
Drug Discovery
AGT Spins Out Addimmune, Focusing on Functional HIV Cure
A-Lists
Top 25 Biotech Companies of 2023
Bioprocessing
Cell Therapy Manufacturing Grapples with Scale-Up
News
Kite Inks Up-to-$4B Deal to Co-Develop Arcellx Myeloma CAR T-Cell Therapy
1
2
3
...
13
Page 1 of 13
Scroll Up
Scroll Up
